These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 32260559)
1. Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the "Universal" CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2. Kuwata T; Yoneda K; Mori M; Kanayama M; Kuroda K; Kaneko MK; Kato Y; Tanaka F Cells; 2020 Apr; 9(4):. PubMed ID: 32260559 [TBL] [Abstract][Full Text] [Related]
2. Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma. Yoneda K; Kuwata T; Chikaishi Y; Mori M; Kanayama M; Takenaka M; Oka S; Hirai A; Imanishi N; Kuroda K; Ichiki Y; Ohnaga T; Tanaka F Cancer Sci; 2019 Feb; 110(2):726-733. PubMed ID: 30499156 [TBL] [Abstract][Full Text] [Related]
3. Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma. Kanayama M; Oyama R; Mori M; Taira A; Shinohara S; Kuwata T; Takenaka M; Yoneda K; Kuroda K; Ohnaga T; Kato Y; Tanaka F Oncol Lett; 2021 Jul; 22(1):522. PubMed ID: 34025789 [TBL] [Abstract][Full Text] [Related]
5. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'. Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987 [TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model. Abe S; Kaneko MK; Tsuchihashi Y; Izumi T; Ogasawara S; Okada N; Sato C; Tobiume M; Otsuka K; Miyamoto L; Tsuchiya K; Kawazoe K; Kato Y; Nishioka Y Cancer Sci; 2016 Sep; 107(9):1198-205. PubMed ID: 27294401 [TBL] [Abstract][Full Text] [Related]
7. Capture of mesothelioma cells with 'universal' CTC-chip. Yoneda K; Chikaishi Y; Kuwata T; Ohnaga T; Tanaka F Oncol Lett; 2018 Feb; 15(2):2635-2640. PubMed ID: 29434985 [TBL] [Abstract][Full Text] [Related]
8. A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody. Abe S; Morita Y; Kaneko MK; Hanibuchi M; Tsujimoto Y; Goto H; Kakiuchi S; Aono Y; Huang J; Sato S; Kishuku M; Taniguchi Y; Azuma M; Kawazoe K; Sekido Y; Yano S; Akiyama S; Sone S; Minakuchi K; Kato Y; Nishioka Y J Immunol; 2013 Jun; 190(12):6239-49. PubMed ID: 23690472 [TBL] [Abstract][Full Text] [Related]
9. Detection and cultivation of circulating tumor cells in malignant pleural mesothelioma. Bobek V; Kacprzak G; Rzechonek A; Kolostova K Anticancer Res; 2014 May; 34(5):2565-9. PubMed ID: 24778078 [TBL] [Abstract][Full Text] [Related]
10. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report. Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209 [TBL] [Abstract][Full Text] [Related]
11. Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesothelioma. Raphael J; Massard C; Gong IY; Farace F; Margery J; Billiot F; Hollebecque A; Besse B; Soria JC; Planchard D Cancer Biomark; 2015; 15(2):151-6. PubMed ID: 25519011 [TBL] [Abstract][Full Text] [Related]
12. Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin. Nishinaga Y; Sato K; Yasui H; Taki S; Takahashi K; Shimizu M; Endo R; Koike C; Kuramoto N; Nakamura S; Fukui T; Yukawa H; Baba Y; K Kaneko M; Chen-Yoshikawa TF; Kobayashi H; Kato Y; Hasegawa Y Cells; 2020 Apr; 9(4):. PubMed ID: 32326079 [TBL] [Abstract][Full Text] [Related]
13. Circulating endothelial cell (CEC) as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM). Yoneda K; Tanaka F; Kondo N; Orui H; Hashimoto M; Takuwa T; Matsumoto S; Okumura Y; Tsubota N; Sato A; Tsujimura T; Kuribayashi K; Fukuoka K; Nakano T; Hasegawa S Ann Surg Oncol; 2012 Dec; 19(13):4229-37. PubMed ID: 22825770 [TBL] [Abstract][Full Text] [Related]
14. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter. Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633 [TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer. Kanayama M; Kuwata T; Mori M; Nemoto Y; Nishizawa N; Oyama R; Matsumiya H; Taira A; Shinohara S; Takenaka M; Yoneda K; Kuroda K; Ohnaga T; Tanaka F Cancer Sci; 2022 Mar; 113(3):1028-1037. PubMed ID: 34964211 [TBL] [Abstract][Full Text] [Related]
16. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer. Yang C; Zhang N; Wang S; Shi D; Zhang C; Liu K; Xiong B J Transl Med; 2018 May; 16(1):139. PubMed ID: 29792200 [TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients. Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504 [TBL] [Abstract][Full Text] [Related]
18. Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma. Stockhammer P; Ploenes T; Theegarten D; Schuler M; Maier S; Aigner C; Hegedus B Lung Cancer; 2020 Jan; 139():124-132. PubMed ID: 31778960 [TBL] [Abstract][Full Text] [Related]
19. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells. Lin M; Chen JF; Lu YT; Zhang Y; Song J; Hou S; Ke Z; Tseng HR Acc Chem Res; 2014 Oct; 47(10):2941-50. PubMed ID: 25111636 [TBL] [Abstract][Full Text] [Related]
20. BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival. Bahnasy AA; El-Din RS; Sabri NA; Abdel-Rahman CA; Bastawisy AE Cancer Genet; 2018 Dec; 228-229():83-92. PubMed ID: 30553477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]